Table 3.
Analysis of clinical cure and 28-day mortality in patients with ventilator-associated pneumonia due to S. maltophilia receiving tigecycline or fluoroquinolones
| Analysis (tigecycline vs. fluoroquinolones) | Odds ratio (95% CI) | p |
|---|---|---|
| Clinical cure | ||
| Crude unadjusted analysis | 0.27 (0.10–0.67) | 0.006 |
| Multivariable logistic regression | 0.32 (0.12–0.86) | 0.026 |
| Inverse probability of treatment weighted model | 0.75 (0.61–0.93) | 0.008 |
| 28-Day mortality | ||
| Crude unadjusted analysis | 2.38 (0.96–6.23) | 0.070 |
| Multivariable logistic regression | 1.64 (0.58–4.77) | 0.355 |
| Inverse probability of treatment weighted model | 1.14 (0.93–1.39) | 0.195 |